One Dead, Eight Hospitalized in Listeria Outbreak Linked to Recalled Soft Cheese
One person has died and at least eight others have been hospitalized in a listeria outbreak traced to requesón soft cheese manufactured by Clover Hill Dairy in Maryland, distributed across multiple states from May 4-30. Listeria is a bacteria that causes potentially life-threatening food poisoning, particularly for vulnerable populations including pregnant women, young children, and elderly adults. The FDA has urged consumers to avoid recalled products sold under multiple brand names, though health officials warn the actual number of illnesses is likely higher than reported.
A listeria outbreak linked to soft cheese has resulted in one confirmed death and eight hospitalizations across Maryland, New York, and Virginia, with the CDC noting the true number of illnesses is likely higher since some people recover without medical care or testing. The contaminated requesón cheese was manufactured by Clover Hill Dairy in Mechanicsville, Maryland, and distributed from May 4 through May 30 through bulk distributors, retail stores, and direct sales across six states and Washington, DC. The affected cheese was repackaged and sold under multiple brand names including Kesso, Quesos La Ricura, Izalco, De Mi Pueblo, and Rio Lindo, complicating consumer identification of recalled products. Listeria bacteria can cause severe complications in vulnerable populations including pregnant women, young children, adults over 65, and immunocompromised individuals, though it typically causes milder symptoms like fever and muscle pain in healthy people. The FDA has advised consumers to discard recalled products or return them for refunds, and cautioned that the investigation is ongoing with additional contaminated items potentially to be identified.
What different sources said
- New York PostRight
One person dead — and others hospitalized — in listeria outbreak linked to recalled cheese
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.